3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
Launched by MAYO CLINIC · Jan 19, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of imaging technology called 3D ultrasound (3D-US), which uses sound waves to create detailed images of lymph nodes in patients with breast cancer. The goal is to see how well this new method works in evaluating lymph nodes, which can be important for understanding the spread of cancer and planning treatment.
To participate in this trial, you need to be a woman aged 18 or older who has undergone a lymph node biopsy or had a lymph node clip placed as part of your regular care. If you join, you can expect to have a 3D ultrasound performed, which is a non-invasive procedure that doesn't involve radiation. The study is currently recruiting participants, and it's important to know that certain individuals, like prisoners or those who can't give consent, are not eligible to participate. Overall, this trial aims to improve how we use imaging technology to help patients with breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with lymph node biopsy or lymph node clip placement as per routine clinical care.
- • Age of 18 or older.
- Exclusion Criteria:
- • Vulnerable subjects such as prisoners and adults lacking capacity to consent.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Shigao D Chen, PhD
Principal Investigator
Mayo Clinic in Rochester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials